PATENT CLAIM ANALYSIS

Application Number: 16323529
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-05
Patent Classification: ["514", "253090"]

Abstract:
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.

Claim (Index 3):
A compound according to  claim 1 , or a salt thereof, wherein R 1  is phenyl optionally substituted by one or two substituents independently selected from C 1-6 alkyl, C 1-6 alkoxy, halogen, \u2014CF 3  and \u2014NO 2 .

Metadata:
- Claim Count in Document: 9.0
- Percentile: 99.0
- Lexical Diversity: 1.53571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13633230', '13633348', '13633320', '16073355', '12768775']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8186065880578915
- 35 USC 102 Novelty (BERT): 0.5695286441352143
- Combined Prediction Score: 0.7936987936656238
- Mean Citation Score: 456.76396000000005
- Max Citation Score: 497.2675
- Similarity Product: 322.2901611053944

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test